Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6729 - 6736 of 12008 results
Hot-Tubbing of Experts in Arbitration
August 28, 2017| News
Medical Co. In FCA Case Looks To Dodge Retaliation Claims
August 28, 2017| News
Massachusetts Receives Nearly Four Dozen Bids in Response to Request for Proposals for Renewable Energy Generation
August 25, 2017| Blog| Viewpoint
Massachusetts Moves Forward with Efforts to Shore up MassHealth
August 24, 2017| Blog| Viewpoint
In a Reversal, Federal Circuit Finds Data Processing Claims Patent-Eligible Under Section 101 in Visual Memory v. NVIDIA
August 23, 2017| Blog| Viewpoint
Implied False Certification Theory Fails in FCA Case Against Billing Agent
August 23, 2017| Blog| Viewpoint
The Four Things That Surprised Us in the EpiPen False Claims Settlement
August 23, 2017| Blog| Viewpoint
Medicare to Narrow Scope of Health-Care Provider Audits
August 23, 2017| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|